OTC · CMPD
CompuMed, Inc.
$5.99-$0.09 (-1.48%)
CompuMed, Inc.’s quoted price sits in the upper half of its reported 52-week range, 23.89% below the high.
Loading market information…
OTC · VYCO · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Vycor Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Vycor Medical, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Vycor Medical, Inc. (VMI) is dedicated to the creation, development, and commercialization of neurological medical devices and therapeutic solutions, operating in both the United States and European markets. The company's operations are divided into two primary business units. The Vycor Medical division specializes in neurosurgical instrumentation, providing devices such as the ViewSite Brain Access System—a critical retraction and access tool used in brain and spine surgeries. Conversely, the NovaVision segment delivers advanced, non-invasive, computer-based rehabilitation programs aimed at helping individuals with vision impairments resulting from strokes or other brain injuries. VMI has also established a strategic license and transition agreement with HelferApp GmbH, authorizing HelferApp to distribute NovaVision's products and therapies to patients and healthcare providers in Austria and Switzerland. The company's main clientele consists of hospitals and various medical professionals. Established in 2005, Vycor Medical, Inc. is headquartered in Boca Raton, Florida, and functions as a subsidiary of Fountainhead Capital Management Limited.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:17 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$5.99-$0.09 (-1.48%)
CompuMed, Inc.’s quoted price sits in the upper half of its reported 52-week range, 23.89% below the high.
$1.94+$0.02 (+0.78%)
HealthLynked Corp.’s quoted price sits in the lower half of its reported 52-week range, 70.15% below the high.
$0.06$0.00 (0.0%)
Reflect Scientific, Inc.’s quoted price sits in the upper half of its reported 52-week range, 17.24% below the high.
CA$0.05CA$0.00 (0.0%)
Telo Genomics Corp.’s quoted price sits in the lower half of its reported 52-week range, 52.38% below the high.
$0.00$0.00 (0.0%)
REMSleep Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.22% below the high.
$0.03$0.00 (0.0%)
Fuse Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.5% below the high.
$0.11$0.00 (0.0%)
LFTD Partners Inc.’s quoted price sits in the lower half of its reported 52-week range, 63.33% below the high.
CA$0.03CA$0.00 (0.0%)
Therma Bright Inc.’s quoted price sits in the lower half of its reported 52-week range, 72.73% below the high.
